New patent for Myovant Sciences drug MYFEMBREE
Annual Drug Patent Expirations for MYFEMBREE Myfembree is a drug marketed by Myovant Sciences and is included in one NDA. […]
Patent Added
New patent for Eli Lilly drug ZEPBOUND
Annual Drug Patent Expirations for ZEPBOUND Zepbound is a drug marketed by Eli Lilly And Co and is included in
New patent for Jazz Pharms drug XYREM
Annual Drug Patent Expirations for XYREM Xyrem is a drug marketed by Jazz Pharms and is included in one NDA.
New patent for Beigene drug BRUKINSA
Annual Drug Patent Expirations for BRUKINSA Brukinsa is a drug marketed by Beigene and is included in one NDA. It
New patent for Tolmar drug ELIGARD KIT
Annual Drug Patent Expirations for ELIGARD+KIT Eligard Kit is a drug marketed by Tolmar and is included in four NDAs.
New patent for Horizon Therap drug RAVICTI
Annual Drug Patent Expirations for RAVICTI Ravicti is a drug marketed by Horizon Therap Us and is included in one
New patent for Agepha Pharma drug LODOCO
Annual Drug Patent Expirations for LODOCO Lodoco is a drug marketed by Agepha Pharma Fz and is included in one
New patent for Abbvie drug UBRELVY
Annual Drug Patent Expirations for UBRELVY Ubrelvy is a drug marketed by Abbvie and is included in one NDA. It
New patent for Norton Waterford drug QVAR REDIHALER
Annual Drug Patent Expirations for QVAR+REDIHALER Qvar Redihaler is a drug marketed by Norton Waterford and is included in one
New patent for Norton Waterford drug QVAR REDIHALER Read Post »
